Belzutifan special drug use results survey in von Hippel-Lindau (VHL) disease-associated tumors: a post-authorization safety study (PASS) (MK-6482-046) First published 20/02/2026 Last updated 20/02/2026 EU PAS number:EUPAS1000000881 Study Planned